Glivec proven effective in treatment of GIST, but linked to SJS
The FDA has approved a new treatment to reduce the risk of cancer returning in patients with gastrointestinal stomal tumors, a disease also known as GIST, however the medication has been linked to Stevens Johnson Syndrome, or SJS.